Pneumonitis
MONDO:0043905An inflammatory process affecting the lung parenchyma. It is a milder form of lung inflammation compared to pneumonia.
Also known as: inflammation of lung parenchyma, lung parenchyma inflammation, pneumonitis
646 clinical trials for this condition and its sub-types, 15 tagged with Pneumonitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Pneumonitis
-
Pneumonia 327 trials · 611 incl. sub-types
11 sub-types
- Idiopathic interstitial pneumonia 10 trials · 219 incl. sub-types Sub-types →
- Bacterial pneumonia 28 trials · 65 incl. sub-types Sub-types →
- Viral pneumonia 27 trials Sub-types →
- Pneumocystosis 19 trials
- Recurrent pneumonia 3 trials
- Bronchopneumonia 1 trial
- Acute fibrinous and organizing pneumonia 0 trials
- Bronchiolocentric pattern of interstitial pneumonia 0 trials
- Contagious pleuropneumonia 0 trials
- Eosinophilic pneumonia 0 trials Sub-types →
- Pleuropneumonia 0 trials
-
Hypersensitivity pneumonitis 25 trials · 30 incl. sub-types
14 sub-types
- Fibrotic hypersensitivity pneumonitis 9 trials
- Ventilation pneumonitis 2 trials
- Bird fancier's lung 1 trial
- Non-fibrotic hypersensitivity pneumonitis 1 trial
- Bagassosis 0 trials
- Cork-handlers' disease 0 trials
- Farmer's lung disease 0 trials
- House allergic alveolitis 0 trials
- Hypersensitivity pneumonitis, familial 0 trials
- Idiopathic chronic eosinophilic pneumonia 0 trials
- Malt worker's lung 0 trials
- Maple bark strippers' lung 0 trials
- Mushroom workers' lung 0 trials
- Sick building syndrome 0 trials
-
Radiation pneumonitis 20 trials
-
Aspiration pneumonitis 2 trials
1 sub-type
- Lipid pneumonia 0 trials
-
Ichthyosis prematurity syndrome 1 trial
-
Toxic pneumonitis 0 trials
Most studied deeper sub-types
-
Can a soy compound shield lungs from radiation damage?
Disease control Recruiting nowThis phase II trial tests whether a drug called BIO 300, made from a soy compound, can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease. About 25 participants will receive BIO 300 along wi…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Sep 18, 2026 00:00 UTC
-
Could a simple asthma drug prevent a dangerous immunotherapy side effect?
Disease control Recruiting nowThis study tests whether using inhaled budesonide (a steroid commonly used for asthma) for one year can stop lung inflammation from coming back in cancer patients who had a serious immune reaction to immunotherapy. About 94 adults with solid tumors who recently had lung inflammat…
Phase 2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
New hope for lung injury: drug may repair radiation and immunotherapy damage
Disease control Recruiting nowThis study tests if the drug pirfenidone can help people with lung damage caused by radiation therapy (with or without immunotherapy). About 298 adults with certain cancers who received chest radiation will take pirfenidone or a placebo for 24 weeks. The goal is to see if the dru…
Phase 2/3 • Sponsor: Beijing Continent Pharmaceutical Co, Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New scan could reveal hidden lung inflammation
Diagnosis Recruiting nowThis early-phase study tests a radioactive tracer called Cu-DOTA-ECL1i that binds to certain inflammatory cells in the lungs. Researchers will use PET scans to see how the tracer spreads in people with fibrotic lung disease, comparing it to CT scans and clinical status. The goal …
Early phase 1 • Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 12:28 UTC
-
Deep-Breathing device may shield lung cancer patients from radiation side effects
Symptom relief Recruiting nowThis study tests whether using an incentive spirometer—a device that encourages deep breathing—can lower the risk of lung inflammation (pneumonitis) in people with advanced lung cancer receiving chemotherapy and radiation. About 100 participants will use the device 10 times every…
Sponsor: The Cooper Health System • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Your cough could reveal hidden lung disease
Knowledge-focused Recruiting nowThis study aims to develop a simple, non-invasive way to detect lung diseases like cancer, asthma, and COPD by analyzing DNA and proteins from cough samples. Researchers will collect cough specimens from 2000 adults, including smokers and non-smokers, and compare them to samples …
Sponsor: Albert Einstein College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC